PDF / 63 KB 
collectBayerNews_20080421_0173_en.pdf BayerNews_20080421_0173_en.pdf
Leverkusen, April 21, 2008 - Bayer confirmed that Bayer Schering Pharma AG and
Bayer HealthCare Pharmaceuticals Inc. filed a patent infringement lawsuit in
U.S. Federal Court in the Southern District of New York (New York) against
Watson Pharmaceuticals, Inc., Watson Laboratories, Inc. and Sandoz, Inc. Bayer
Schering Pharma's suit concerns Watson's and Sandoz's respective applications
to the FDA for approval to market a generic form of Bayer Schering Pharma's
oral contraceptive Yasmin®. The patent at issue in the suit is Bayer Schering
Pharma's U.S. Patent No. 5,569,652.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of
health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary
of Bayer AG, is one of the world's leading, innovative companies in the
healthcare and medical products industry and is based in Leverkusen, Germany.
The company combines the global activities of the Animal Health, Consumer Care,
Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business
operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to
discover and manufacture products that will improve human and animal health
worldwide. Find more information at www.bayerhealthcare.com.
About Bayer Schering Pharma
Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company.
Its research and business activities are focused on the following areas:
Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized
Therapeutics and Women's Healthcare. With innovative products, Bayer Schering
Pharma aims for leading positions in specialized markets worldwide. Using new
ideas, Bayer Schering Pharma aims to make a contribution to medical progress
and strives to improve the quality of life. Find more information at
www.bayerscheringpharma.de.
